GlassScriptPhysician profile
Sharon A Walters
NPI 1396952230
$18,700.11
in general payments reported to CMS, 2019-2025
17 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,703 · 2022: $7,406 · 2023: $1,213 · 2024: $167 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,045 · Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,045.00 |
| Food and Beverage | $546.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14,880.93 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $3,170.25 | 2021-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Corium, LLC | $203.23 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $160.86 | 2021-2025 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $52.16 | 2024 | |
| Pfizer INC. | $45.46 | 2024-2025 | |
| Kyowa Kirin, INC. | $27.97 | 2023 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $22.99 | 2024 | Flumist Quadrivalent |
| Tris Pharma INC | $20.25 | 2025 | Onyda Xr |
| Genzyme Corporation | $18.33 | 2022 | |
| Abiomed | $17.72 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.30 | 2021 | |
| Neos Therapeutics, LP | $15.68 | 2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $15.39 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $14.21 | 2025 | Ycanth |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $12.86 | 2023 | |
| Ironshore Pharmaceuticals INC. | $5.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.